Nihilodermia in psychodermatology;Nihilodermie in der psychodermatologie

Hautarzt

Volumn 58, Issue 5, 2007, Pages 427-434

  Harth, W ^a   Hermes, B ^a   Seikowski, K ^b   Gieler, U ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Body Dysmorphic Disorder; Hypochondria; Nihilodermia; Psychodermatology; Somatoform

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; EMOTIONAL DISORDER; HUMAN; HYPOCHONDRIASIS; NIHILODERMIA; PAIN; PARESTHESIA; PRURITUS; PSYCHOTHERAPY; REVIEW; SOCIAL PSYCHOLOGY; SOMATOFORM DISORDER;

AFFECTIVE SYMPTOMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOCHONDRIASIS; PATIENT CARE TEAM; RECURRENCE; REFERRAL AND CONSULTATION; SICK ROLE; SKIN DISEASES; SOMATOFORM DISORDERS;

EID: 34248327876     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1329-6     Document Type: Review

References (36)

1. Cotterill JA (1996) Dermatologic nondisease. Dermatol Clin14: 439-445
2. Gupta MA, Gupta AK (2006) Medically unexplained cutaneous sensory symptoms may represent somatoform dissociation: an empirical study.J Psychosom Res 60: 131-136
3. Stangier U, Gieler U (1997) Somatoforme Störungen in der Dermatologie. Psychotherapie 2: 91-101
4. Hontschik B, Uexküll U (Hrsg) (1999) Psychosomatik in der Chirurgie. Schattauer Verlag, Stuttgart
5. Beck D (1977) Das Koryphäen-Killer-Syndrom. Dtsch Med Wochenschr 102: 303-307
6. Sass H, Wittchen H-U, Zaudig M (Hrsg) (2001) Diagnostisches und Statistisches Manual Psychischer Störungen DSM-IV. Hogrefe Verlag für Psychologie, Berlin Toronto Seattle
7. Eberlein-König B, Behrendt H, Ring J (2002) Idiopathische Umweltintoleranz (MCS, Öko-Syndrom) - neue Entwicklungen. Allergo J 11: 434-441
8. Gottwald B, Kupfer J, Traenckner I et al. (2002) Psychological, allergic, and toxicological aspects of patients with amalgam-related complaints. Psychother Psychosom 71: 223-232
9. Harth W, Gieler U (Hrsg) (2006) Psychosomatische Dermatologie. Springer, Heidelberg Berlin New York
10. Ishigooka J, Iwao M, Suzuki M et al. (1998) Demographic features of patients seeking cosmetic surgery. Psychiatry Clin Neurosci 52: 283-287
11. Bohne A, Keuthen NJ, Wilhelm S et al. (2002) Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison. Psychosomatics 43: 486-490
12. Harth W, Linse R (2001) Botulinophilia: contraindication for therapy with botulinum toxin. Int J Clin Pharmacol Ther 39: 460-463
13. Glaser DA, Kaminer MS (2005) Body dysmorphic disorder and the liposuction patient. Dermatol Surg 31: 559-551
14. Phillips KA, Grant J, Siniscalchi J, Albertini RS (2001) Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics 42: 504-510
15. Phillips KA, Didie ER, Menard W et al. (2006) Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res 141: 305-314
16. Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26: 926-931
17. Brosig B, Kupfer J, Niemeier V, Gieler U (2001) The Dorian Gray Syndrome: psychodynamic need for hair growth restorers and other fountains of youth. Int J Clin Pharmacol Ther 39: 279-283
18. Huang W, Rothe MJ, Grant-Kels JM (1996) The burning mouth syndrome. J Am Acad Dermatol 34: 91-98
19. Niemeier V, Kupfer J, Harth W et al. (2002) Sind Patienten mit Glossodynie psychisch unauffällig? Eine psychodiagnostisch schwer fassbare Erkrankung. Psychother Psychosom Med Psychol 52: 425-432
20. Trueb RM (1997) Trichodynie. Hautarzt 48: 877-880
21. Rebora A, Semino MT, Guarrera M (1996) Trichodynia. Dermatology 192: 292-293
22. Kivanc-Altunay I, Savas C, Gokdemir G et al. (2003) The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol 42: 691-693
23. Luzzi GA (2002) Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management. J Eur Acad Dermatol Venereol 16: 253-256
24. Brähler E, Berberich H, Kupfer J (2002) Sexualität und Psychosomatik der chronischen Beckenbeschwerden des Mannes. In: Seikowski K, Starke K (Hrsg) Sexualität des Mannes. Pabst, Lengerich, S 81-90
25. Scialli AR (1999)Evaluating chronic pelvic pain. A consensus recommendation. Pelvic Pain Expert Working Group. J Reprod Med 44: 945-952
26. Stewart DE, Reicher AE, Gerulath AH, BoydellKM (1994) Vulvodynia and psychological distress. Obstet Gynecol 84: 587-590
27. Niemeier V, Kupfer J, Gieler U (2000) Observations during an itch- inducing lecture. Dermatol Psychosom 1: 15-18
28. Schultz-Amling W, Köhler-Weisker A (1996) Pruritus ani. In: Gieler U, Bosse KA (Hrsg) Seelische Faktoren bei Hautkrankheiten 2. Aufl. Huber-Verlag, Bern, S 105-112
29. Rief W, Hiller W (Hrsg) (1992) Somatoforme Störungen. Huber-Verlag, Bern
30. Krege S, Ludwig M, Kloke M, Rubben H (2003) Chronic pain syndrome in uorology. Urologe A 42: 669-674
31. McKay D (1999) Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif 23: 620-629
32. Wilhelm S, Otto MW, Lohr B, Deckersbach T (1999) Cognitive behavior group therapy for bodydysmorphic disorder: A case series. Behav Res Ther 3: 71-75
33. Hollander E, Aronowitz BR (1999) Comorbid social anxiety and body dysmorphic disorder: Managing the complicated patient. J Clin Psychiatry (Suppl 9) 60: 27-31
34. Phillips KA, Albertini RS, Rasmussen SA (2002) A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 59: 381-388
35. Wesselmann U, Burnett AL, Heinberg LJ (1997) The urogenital and rectal pain syndromes. Pain 73: 269-294
36. Sasaki K, Smith CP, Chuang YC et al. (2001) Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 7: 47-49